These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2946262)

  • 21. In-vitro activity of trospectomycin sulphate against Mycoplasma and Ureaplasma species isolated from humans.
    Yancey RJ; Klein LK
    J Antimicrob Chemother; 1988 Jun; 21(6):731-6. PubMed ID: 2970452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of Haemophilus ducreyi. A study.
    Sng EH; Lim AL; Rajan VS; Goh AJ
    Br J Vener Dis; 1982 Aug; 58(4):239-42. PubMed ID: 6980682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial activity in vitro of 10 quinolones against 20 strains of Legionella pneumophila].
    Deforges L; Fournet MP; Soussy CJ; Duval J
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):631-3. PubMed ID: 3534757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
    Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
    Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antimycoplasmal activities of ofloxacin and commonly used antimicrobial agents on Mycoplasma gallisepticum].
    Takahashi I; Yoshida T
    Jpn J Antibiot; 1989 May; 42(5):1166-72. PubMed ID: 2526260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
    Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect ofloxacin on Haemophilus influenza, Streptococcus pneumoniae and Neisseria meningitidis. Comparison with similar molecules].
    Dabernat H; Delmas C; Lareng MB
    Pathol Biol (Paris); 1985 May; 33(5):385-8. PubMed ID: 3162140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
    Slaney L; Chubb H; Ronald A; Brunham R
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
    Le Saux NM; Slaney LA; Plummer FA; Ronald AR; Brunham RC
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1153-4. PubMed ID: 2959199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.
    Zurenko GE; Yagi BH; Vavra JJ; Wentworth BB
    Antimicrob Agents Chemother; 1988 Feb; 32(2):216-23. PubMed ID: 2966608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on susceptibility of isolated organisms from pediatric infections against various antimicrobial agents].
    Fujii R; Shinozaki T; Meguro H; Arimasu O; Yoshioka H; Fujita K; Sakata H; Maruyama S; Wagatsuma Y; Fukushima N
    Jpn J Antibiot; 1988 Jul; 41(7):841-53. PubMed ID: 3050184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro antibacterial activity of three new quinolone derivatives: rosoxacin, norfloxacin, pefloxacin.
    Husson MO; Izard D; Leclerc H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):283-6. PubMed ID: 6241772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of six quinolone derivatives against Neisseria gonorrhoeae.
    Lefèvre JC; Tempesta MC; Gaubert E; Lareng MB
    Chemotherapy; 1988; 34(4):315-7. PubMed ID: 2850138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H; Quentin C; de Barbeyrac B; Bebear C
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antibiotics against bovine mycoplasmas and ureaplasmas.
    Truscott RB; Ruhnke HL
    Can J Comp Med; 1984 Apr; 48(2):171-4. PubMed ID: 6232992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative in-vitro activity of pefloxacin.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.